This inventor holds 2 USPTO granted patents. Top assignee: Massachusetts Institute of Technology. Active years: 1998-2001.
Company Filing History:
Years Active: 1998-2001
Title: The Innovations of Andre Darveau
Introduction
Andre Darveau is a notable inventor based in St. Foy, CA. He has made significant contributions to the field of genetics, particularly in the study of the Wilms' tumor gene. With a total of 2 patents, his work has implications for understanding kidney and gonadal tissue development.
Latest Patents
Darveau's latest patents focus on the localization and characterization of the Wilms' tumor gene associated with the 11p3 locus on the human chromosome. This gene encodes a transcription unit approximately 50 kb in size and an mRNA of about 3 kb, predominantly expressed in kidney and gonadal tissue. The gene undergoes alternative splicing, producing four very similar mRNA transcripts. The polypeptides encoded by the Wilms' tumor DNA include four "zinc fingers" and a region rich in proline and glutamine, suggesting a role in transcription regulation.
Career Highlights
Andre Darveau is affiliated with the Massachusetts Institute of Technology, where he continues to advance research in genetics. His work has garnered attention for its potential impact on cancer research and treatment.
Collaborations
Darveau has collaborated with notable colleagues, including Katherine M Call and David E Housman, contributing to a rich environment of innovation and discovery.
Conclusion
Andre Darveau's contributions to the field of genetics, particularly through his patents on the Wilms' tumor gene, highlight his role as an influential inventor. His work continues to pave the way for advancements in understanding genetic disorders.